Youssef Younossi

5.5k total citations · 8 hit papers
27 papers, 4.0k citations indexed

About

Youssef Younossi is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Youssef Younossi has authored 27 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 20 papers in Hepatology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Youssef Younossi's work include Liver Disease Diagnosis and Treatment (27 papers), Liver Disease and Transplantation (15 papers) and Alcohol Consumption and Health Effects (7 papers). Youssef Younossi is often cited by papers focused on Liver Disease Diagnosis and Treatment (27 papers), Liver Disease and Transplantation (15 papers) and Alcohol Consumption and Health Effects (7 papers). Youssef Younossi collaborates with scholars based in United States, Philippines and France. Youssef Younossi's co-authors include Zobair M. Younossi, Maria Stepanova, Pegah Golabi, James M. Paik, Linda Henry, Manirath Srishord, Alita Mishra, Yun Fang, Mariam Afendy and Sharon Hunt and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Youssef Younossi

27 papers receiving 4.0k citations

Hit Papers

The economic and clinical... 2011 2026 2016 2021 2016 2011 2020 2012 2019 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
    2016 916 citations Zobair M. Younossi, Linda Henry et al. Hepatology profile →
  2. Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
    2011 863 citations Zobair M. Younossi, Maria Stepanova et al. Clinical Gastroenterology and Hepatology profile →
  3. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD
    2020 547 citations James M. Paik, Pegah Golabi et al. Hepatology profile →
  4. Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
    2012 431 citations Zobair M. Younossi, Maria Stepanova et al. Medicine profile →
  5. Epidemiology of chronic liver diseases in the USA in the past three decades
    2019 387 citations Zobair M. Younossi, Maria Stepanova et al. Gut profile →
  6. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019
    2021 161 citations Pegah Golabi, James M. Paik et al. Journal of Hepatology profile →
  7. Global burden of NAFLD and chronic liver disease among adolescents and young adults
    2021 153 citations James M. Paik, Khaled W. Kabbara et al. Hepatology profile →
  8. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019
    2023 96 citations James M. Paik, Linda Henry et al. Hepatology Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youssef Younossi United States 18 3.5k 1.8k 1.3k 656 526 27 4.0k
Manirath Srishord United States 13 3.6k 1.0× 1.6k 0.9× 1.8k 1.3× 668 1.0× 606 1.2× 28 4.0k
Dawn M. Torres United States 23 3.4k 1.0× 1.5k 0.8× 1.5k 1.1× 595 0.9× 479 0.9× 38 3.8k
Eduardo Vilar‐Gómez United States 26 3.9k 1.1× 1.9k 1.1× 1.8k 1.3× 582 0.9× 647 1.2× 76 4.3k
Alina M. Allen United States 32 3.8k 1.1× 2.3k 1.3× 1.2k 0.9× 504 0.8× 837 1.6× 107 4.5k
George Cholankeril United States 31 3.0k 0.8× 1.8k 1.0× 874 0.7× 630 1.0× 604 1.1× 145 4.0k
Wah‐Kheong Chan Malaysia 30 2.8k 0.8× 1.4k 0.8× 1.1k 0.8× 409 0.6× 768 1.5× 112 3.7k
Fatema Nader United States 29 3.4k 1.0× 2.2k 1.2× 1.3k 0.9× 383 0.6× 456 0.9× 76 3.9k
Fabio Nascimbeni Italy 28 4.1k 1.2× 1.5k 0.8× 2.2k 1.7× 785 1.2× 563 1.1× 54 4.8k
Mark Muthiah Singapore 32 2.5k 0.7× 1.2k 0.7× 1.0k 0.8× 496 0.8× 636 1.2× 184 4.1k
Patricia R. Robuck United States 16 2.9k 0.8× 1.6k 0.9× 1.4k 1.0× 405 0.6× 881 1.7× 21 4.0k

Countries citing papers authored by Youssef Younossi

Since Specialization
Citations

This map shows the geographic impact of Youssef Younossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youssef Younossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youssef Younossi more than expected).

Fields of papers citing papers by Youssef Younossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youssef Younossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youssef Younossi. The network helps show where Youssef Younossi may publish in the future.

Co-authorship network of co-authors of Youssef Younossi

This figure shows the co-authorship network connecting the top 25 collaborators of Youssef Younossi. A scholar is included among the top collaborators of Youssef Younossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youssef Younossi. Youssef Younossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paik, James M., Katherine Eberly, Khaled W. Kabbara, et al.. (2023). Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.). Annals of Hepatology. 28(4). 101108–101108. 4 indexed citations
2.
Younossi, Zobair M., James M. Paik, Pegah Golabi, et al.. (2022). The impact of fatigue on mortality of patients with non‐alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005–2010 and 2017–2018. Liver International. 42(12). 2646–2661. 23 indexed citations
3.
Paik, James M., Youssef Younossi, Jillian Kallman Price, et al.. (2022). Sarcopenia, healthy living, and mortality in patients with chronic liver diseases. Hepatology Communications. 6(11). 3140–3153. 22 indexed citations
4.
Paik, James M., et al.. (2021). Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data. Hepatology Communications. 6(1). 90–100. 35 indexed citations
5.
Paik, James M., Khaled W. Kabbara, Katherine Eberly, et al.. (2021). Global burden of NAFLD and chronic liver disease among adolescents and young adults. Hepatology. 75(5). 1204–1217. 153 indexed citations breakdown →
6.
Younossi, Zobair M., et al.. (2021). The Impact of NASH to Liver Transplantations With Hepatocellular Carcinoma in the United States. Clinical Gastroenterology and Hepatology. 20(12). 2915–2917.e1. 13 indexed citations
7.
Golabi, Pegah, et al.. (2021). Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019. Journal of Hepatology. 75(4). 795–809. 161 indexed citations breakdown →
8.
Paik, James M., Khaled W. Kabbara, Katherine Eberly, et al.. (2021). Sa350 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS DRIVING THE GLOBAL BURDEN OF CHRONIC LIVER DISEASE (CLD) AMONG ADOLESCENTS AND YOUNG ADULTS. Gastroenterology. 160(6). S–830. 1 indexed citations
9.
Paik, James M., Youssef Younossi, Linda Henry, Alita Mishra, & Zobair M. Younossi. (2021). Recent Trends in the Global Burden of Hepatitis B Virus: 2007–2017. Gastroenterology. 160(5). 1845–1846.e3. 16 indexed citations
10.
Paik, James M., Pegah Golabi, Youssef Younossi, et al.. (2020). The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007‐2017. Hepatology Communications. 4(12). 1769–1780. 70 indexed citations
11.
Paik, James M., Pegah Golabi, Youssef Younossi, Alita Mishra, & Zobair M. Younossi. (2020). Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD. Hepatology. 72(5). 1605–1616. 547 indexed citations breakdown →
12.
Golabi, Pegah, James M. Paik, Tamoore Arshad, et al.. (2020). Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities. Hepatology Communications. 4(8). 1136–1148. 74 indexed citations
13.
Paik, James M., Pegah Golabi, Youssef Younossi, et al.. (2020). The growing burden of disability related to non-alcoholic fatty liver disease: data from global burden of disease 2007–2017. Journal of Hepatology. 73. S47–S47. 1 indexed citations
14.
Younossi, Zobair M., Maria Stepanova, Youssef Younossi, et al.. (2019). Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 69(3). 564–568. 387 indexed citations breakdown →
15.
Younossi, Zobair M., et al.. (2017). In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered. Liver International. 38(2). 258–265. 31 indexed citations
16.
Younossi, Zobair M., Maria Stepanova, Francesco Negro, et al.. (2012). Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States. Medicine. 91(6). 319–327. 431 indexed citations breakdown →
17.
Younossi, Zobair M., et al.. (2011). Effectiveness of Recommendations for Hepatitis A (HAV) and Hepatitis B (HBV) Vaccinations for Patients With Chronic Liver Disease (CLD). Gastroenterology. 140(5). S–723. 1 indexed citations
18.
Stepanova, Maria, Brian Lam, Youssef Younossi, Manirath Srishord, & Zobair M. Younossi. (2011). Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity. Journal of Viral Hepatitis. 19(5). 341–345. 42 indexed citations
19.
Younossi, Zobair M., Maria Stepanova, Mariam Afendy, et al.. (2011). Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008. Clinical Gastroenterology and Hepatology. 9(6). 524–530.e1. 863 indexed citations breakdown →
20.
Hossain, Noreen, Maria Stepanova, Arian Afendy, et al.. (2010). Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS). Scandinavian Journal of Gastroenterology. 46(4). 479–484. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manirath Srishord Breakdown of academic impact, for papers by Dawn M. Torres Breakdown of academic impact, for papers by Eduardo Vilar‐Gómez Breakdown of academic impact, for papers by Alina M. Allen Breakdown of academic impact, for papers by George Cholankeril Breakdown of academic impact, for papers by Wah‐Kheong Chan Breakdown of academic impact, for papers by Fatema Nader Breakdown of academic impact, for papers by Fabio Nascimbeni Breakdown of academic impact, for papers by Mark Muthiah Breakdown of academic impact, for papers by Patricia R. Robuck
Rankless by CCL
2026